Insider Cluster (4 insiders) ·Filed Aug 10, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 4 insiders, $4.0M total
Actionable Insight • Neutral

The insider selling cluster is too small to convey a meaningful signal. Monitor for larger-scale selling (>0.1% of market cap) or a change in pattern (e.g., CEO/CFO selling without option exercise) before drawing bearish conclusions. The Q2 earnings beat and raised sales guidance are the more relevant near-term drivers.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
MRK ▲ +13.12% at T+20d
NEUTRAL call ✓ call won +13.12% · α vs SPY +14.18% · entry $130.42 → $147.53
Next anchor: T+60d in 5w
Latest observation: T+34 +10.67% FF3 residual α
Entry anchored
Aug 10, 04:17 PM ET
via 1-min bar
T+1d
+1.92%
call +1.92% · α +1.67%
$132.92
settled 7w ago
T+5d
+3.63%
call +3.63% · α +4.04%
$135.16
settled 7w ago
T+20d
+13.12%
call +13.12% · α +14.18%
$147.53
settled 24d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Four Merck executives sold a combined ~$12M in open-market shares over two days following the Q2 2026 earnings release. The total is ~0.004% of Merck's $317.6B market cap — immaterial. Most sales coincide with option exercises and are likely routine post-vesting liquidity events, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$12.0M
Insiders
4

Key Facts

  • 4 insiders sold open-market shares: EVP Guindo Chirfi ($1.97M), EVP David Michael Williams ($6.81M), EVP David R. Maraldo ($2.41M), EVP Richard R. DeLuca ($0.79M)
  • Total open-market sales: ~$11.97M
  • Sales occurred on Aug 5-6, 2026, within 6 days of Merck's Q2 2026 earnings release (Aug 4)
  • Multiple sales were accompanied by derivative exercises (non-cash), indicating routine option monetization
  • Cluster value is 0.004% of market cap — well below the 0.1% materiality threshold

Financial Impact

~$12M in insider sales, negligible relative to $317.6B market cap

insider ownership

Risk Factors

  • No material risk identified from this cluster; routine post-earnings option-related selling

Market Snapshot

Price
$130.45
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MRK-1786393729762
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.28 (−0.45%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.28 (−2.88%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.28 (−4.19%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.28 (+4.90%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.28 (−3.83%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.28 (+5.48%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.28 (+5.70%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.28 (+5.70%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.28 (+7.79%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.28 (+7.79%)
Showing 10 of 20

US Market Status

Market Open — Closes in 4h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 10, 2026